The FDA?s New PowerFriday, August 20, 2010 @ 8:12AMRisk Evaluation and Mitigation Systems - REMS - can be a nightmare for biotechnology companies.
Diet Drug Qnexa Gets Thumbs-Down In Avandia's WakeMonday, July 19, 2010 @ 1:52PMWorries about birth defects and other side effects led to a 10 to 6 vote against a new diet drug by an FDA panel. NPR Story ID: 128560245 read more
Experimental diet pill shows some promise and little riskMonday, July 19, 2010 @ 7:14AMMIKE STOBBE Associated Press ATLANTA -- An experimental diet pill helped about half the people who tried it lose some weight and keep it off a ye ...
Drug Meant to Help Fight Obesity Rejected by FDASunday, July 18, 2010 @ 6:45AMMany people had hopes that a new drug, in its final stages of FDA approval, would help fight obesity in America.
FDA Panel Rejects Highly Anticipated Diet PillFriday, July 16, 2010 @ 6:59PMATLANTA -- A panel of federal health experts dealt a surprising setback Thursday to an anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.
Experimental diet pill shows promise, little riskThursday, July 15, 2010 @ 2:25AMATLANTA -- An experimental diet pill helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a study found.
Vivus' weight-loss drug faces key U.S. testThursday, July 15, 2010 @ 12:37AMWASHINGTON (Reuters) - The first potential U.S. prescription weight-loss pill in more than a decade could move closer to market on Thursday if it can overcome safety hurdles that have plagued diet drugs for years and led to tepid sales despite the growing number of obese Americans.
Vivus' weight-loss drug faces key U.S. testThursday, July 15, 2010 @ 12:00AM* Vivus seeking to sell first new diet pill in a decade
Experimental diet pill shows promise, fewer risksWednesday, July 14, 2010 @ 8:29PMAn experimental diet pill called lorcaserin helped about half the people who tried it lose some weight and keep it off a year later, without the heart problems that some earlier drugs caused, a new study has found.